januvia and glp 1 Schematic presentation of glucagon-like peptide-1 (GLP-1)-dependent New studies back safety of

Supervision: NG

The data suggest that people on GLP-1s discontinuing the medication for pregnancy require closer monitoring for excess weight gain and complications, Jacqueline Maya, MD , a pediatric endocrinologist at Massachusetts General Hospital, told Healio

The vast majority of chin lumps are removed as a straightforward day-case procedure under local anaesthetic

Improper dosing of compounded drugs was identified as a concern for the FDA in an alert released in July

The tablets were provided by Karen (placebo tablets) and Avicenna (NAC tablets) Pharmaceuticals Company

Treatment is typically limited to a maximum of two years